Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention.
O'Shea AE, Valdera FA, Ensley D, Smolinsky TR, Cindass JL, Kemp Bohan PM, Hickerson AT, Carpenter EL, McCarthy PM, Adams AM, Vreeland TJ, Clifton GT, Peoples GE. O'Shea AE, et al. Among authors: kemp bohan pm. Clin Immunol. 2022 Dec;245:109095. doi: 10.1016/j.clim.2022.109095. Epub 2022 Aug 13. Clin Immunol. 2022. PMID: 35973640 Review.
Chemoprevention in familial adenomatous polyposis: past, present and future.
Kemp Bohan PM, Mankaney G, Vreeland TJ, Chick RC, Hale DF, Cindass JL, Hickerson AT, Ensley DC, Sohn V, Clifton GT, Peoples GE, Burke CA. Kemp Bohan PM, et al. Fam Cancer. 2021 Jan;20(1):23-33. doi: 10.1007/s10689-020-00189-y. Epub 2020 Jun 8. Fam Cancer. 2021. PMID: 32507936 Free PMC article. Review.
Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreement.
Kemp Bohan PM, Chick RC, Hickerson AT, Messersmith LM, Williams GM, Cindass JL, Lombardo J, Collins R, Brady RO, Hale DF, Peoples GE, Vreeland TJ, Clifton GT. Kemp Bohan PM, et al. Cancer Immunol Immunother. 2021 May;70(5):1465-1474. doi: 10.1007/s00262-020-02784-5. Epub 2020 Nov 12. Cancer Immunol Immunother. 2021. PMID: 33180182 Free PMC article.
Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer.
Chick RC, Clifton GT, Hale DF, Vreeland TJ, Hickerson AT, Kemp Bohan PM, McCarthy PM, Litton JK, Alatrash G, Murthy RK, Qiao N, Philips A, Lukas J, Holmes JP, Mittendorf EA, Peoples GE. Chick RC, et al. Among authors: kemp bohan pm. Clin Immunol. 2021 Apr;225:108679. doi: 10.1016/j.clim.2021.108679. Epub 2021 Jan 22. Clin Immunol. 2021. PMID: 33485895 Clinical Trial.
Phase I Trial of Encapsulated Rapamycin in Patients with Prostate Cancer Under Active Surveillance to Prevent Progression.
Kemp Bohan PM, Chick RC, O'Shea AE, Vreeland TJ, Hickerson AT, Cindass JL, Ensley DC, Hale D, Clifton GT, Sohn VY, Thompson IM Jr, Peoples GE, Liss MA. Kemp Bohan PM, et al. Cancer Prev Res (Phila). 2021 May;14(5):551-562. doi: 10.1158/1940-6207.CAPR-20-0383. Epub 2021 Jan 29. Cancer Prev Res (Phila). 2021. PMID: 33514567 Clinical Trial.
38 results